Eltrombopag N-Oxide
✓
100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
⬡
0 % Toleranz bei der Produktqualität

Lagerstandorte

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

2734533-17-4Eltrombopag N-Oxide

● Auf Lager

Katalog-Nr.::VE0010338
CAS-Nr.::2734533-17-4
Summenformel::C25H22N4O5
Molare Masse::458.47 g/mol

Zusätzliche Informationen zu CAS 2734533-17-4

Parent drug

Eltrombopag

IUPAC-Name

3′-(2-(1-(3, 4-Dimethylphenyl)-3-methyl-5-oxo-1, 5-dihydro-4H-pyrazol-4-ylidene)-1-hydroxyhydrazinyl)-2′-hydroxy-[1, 1′-biphenyl]-3-carboxylic acid

Pharmakopöe-Synonyme

N/A

Other Synonyms

N/A

Smile

O=C(C1=CC(C2=CC=CC(N(O)/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C\3=O)=C2O)=CC=C1)O

InChI

InChI=1S/C25H22N4O5/c1-14-10-11-19(12-15(14)2)28-24(31)22(16(3)26-28)27-29(34)21-9-5-8-20(23(21)30)17-6-4-7-18(13-17)25(32)33/h4-13,30,34H,1-3H3,(H,32,33)/b27-22+

Beschreibung

The compound Eltrombopag N-Oxideis a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Eltrombopag. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes.

Angebot anfordern

„*“ zeigt erforderliche Felder an

Dieses Feld dient zur Validierung und sollte nicht verändert werden.
Products quotation
Name
Url